The angiotensin-I converting enzyme gene I/D variation contributes to end-stage renal disease risk in Chinese patients with type 2 diabetes receiving hemodialysis | |
Lu, Ming; Zhang, Jianzhong; Li, Ming; Ge, Xiaoxu; Dai, Xu; Zhao, Jiao; Fu, Mingzhou; Wang, Tao; Fang, Xiyao; Li, Can | |
刊名 | MOLECULAR AND CELLULAR BIOCHEMISTRY
![]() |
2016 | |
卷号 | 422期号:1-2 |
关键词 | Angiotensin-I converting enzyme (ACE) I/D variation Type 2 diabetes mellitus (T2DM) End-stage renal disease (ESRD) Hemodialysis |
ISSN号 | 0300-8177 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3643761 |
专题 | 上海中医药大学 |
推荐引用方式 GB/T 7714 | Lu, Ming,Zhang, Jianzhong,Li, Ming,et al. The angiotensin-I converting enzyme gene I/D variation contributes to end-stage renal disease risk in Chinese patients with type 2 diabetes receiving hemodialysis[J]. MOLECULAR AND CELLULAR BIOCHEMISTRY,2016,422(1-2). |
APA | Lu, Ming.,Zhang, Jianzhong.,Li, Ming.,Ge, Xiaoxu.,Dai, Xu.,...&Jia, Weiping.(2016).The angiotensin-I converting enzyme gene I/D variation contributes to end-stage renal disease risk in Chinese patients with type 2 diabetes receiving hemodialysis.MOLECULAR AND CELLULAR BIOCHEMISTRY,422(1-2). |
MLA | Lu, Ming,et al."The angiotensin-I converting enzyme gene I/D variation contributes to end-stage renal disease risk in Chinese patients with type 2 diabetes receiving hemodialysis".MOLECULAR AND CELLULAR BIOCHEMISTRY 422.1-2(2016). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论